Everpure: RWC Trust sells $7.72M in common shares

The listed shares are identified as founder shares acquired from Everpure on October 10, 2009; earlier RWC Trust sales are also listed.

Rhea-AI Filing Summary

Everpure, Inc. (P) is the issuer for a reported sale by The RWC Trust U/A dated February 8, 2011, of 50,000 common shares on October 12, 2026, with an aggregate market value of $7,724,500. Morgan Stanley Smith Barney LLC is listed as broker, and the securities information lists 333,227,251 shares outstanding. Earlier records list RWC Trust sales of 50,000 shares each on August 10 and September 10, 2026, as 10b5-1 sales. Joseph T. Fitzgerald signed as trustee.

Key Figures

Reported sale: 50,000 shares Aggregate market value: $7,724,500 Shares outstanding: 333,227,251 shares

3 metrics

Reported sale 50,000 shares Common shares; October 12, 2026

Aggregate market value $7,724,500 Reported sale dated October 12, 2026

Shares outstanding 333,227,251 shares Securities information

Key Terms

Rule 144, 10b5-1 Sales, Founders Shares

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales regulatory

"10b5-1 Sales for THE RWC TRUST U/A DTD 02/08/2011"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Founders Shares financial

"Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Everpure (P) shares did RWC Trust sell, and what was their reported value?

The RWC Trust reported a sale of 50,000 Everpure common shares on October 12, 2026, with an aggregate market value of $7,724,500.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 08:24 AM EDT Accepted by SEC EDGAR 10/13/2026 - 08:24 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001651902
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Everpure, Inc.
SEC File Number	001-37570
Address of Issuer	2555 Augustine Dr. Santa Clara CALIFORNIA 95054
Phone	8003797873
Name of Person for Whose Account the Securities are To Be Sold	THE RWC TRUST U/A DTD 02/08/2011
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	7724500.00	333227251	10/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/10/2009	Founders Shares	Issuer			50000	10/10/2009	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	09/25/2026	100000	12463060.00
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	09/24/2026	100000	11596320.00
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	09/22/2026	100000	11055830.00
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	09/21/2026	100000	11034990.00
10b5-1 Sales for THE EEC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	Common	09/10/2026	50000	4747470.00
10b5-1 Sales for THE RWC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	COMMON	09/10/2026	50000	4747470.00
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	08/14/2026	64815	7612048.60
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	08/13/2026	100000	11720590.00
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	08/12/2026	100000	11146959.11
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	08/11/2026	100000	10438759.48
10b5-1 Sales for THE EEC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	Common	08/10/2026	50000	4935020.00
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	08/10/2026	100000	9525958.13
10b5-1 Sales for THE RWC TRUST U/A DTD 02/08/2011 2555 Augustine Dr. Santa Clara CA 95054	COMMON	08/10/2026	50000	4935020.00
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	08/07/2026	35185	3167047.59
10b5-1 Sales for THE COLGROVE FAM CHARITABLE REM TRU/A DTD 04/05/2024 2555 Augustine Dr. Santa Clara CA 95054	Common	08/04/2026	89720	7685361.37

144: Remarks and Signature

Remarks	Sales that were executed on October 12, 2026 are being reported on this Form 144 filed on October 13, 2026 given the EDGAR system was not accepting filings on October 12, 2026 in observance of the federal holiday.
Date of Notice	10/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	01/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joseph T Fitzgerald TTEE
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)